Skip to main content
SpringerLink
Log in

Macrolides and upper airway/sinus disease

  • Chapter
Antibiotics as Anti-Inflammatory and Immunomodulatory Agents

Part of the book series: Progress in Inflammation Research ((PIR))

  • 936 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, Sugiyama Y (1987) Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 25: 632–42

    Google Scholar 

  2. Kikuchi S, Suzaki H, Aoki A, Ito O, Nomura Y (1991) Clinical effect of long-term low dose erythromycin therapy for chronic sinusitis. Pract Otol (Kyoto) 84: 41–7

    Google Scholar 

  3. Hashiba M, Baba S (1996) Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol (Suppl) 525: 73–8

    Google Scholar 

  4. Kimura N, Nishioka K, Nishizaki K, Ogawa T, Naitou Y, Masuda Y (1997) Clinical effect of low-dose, long-term roxithromycin chemotherapy in patients with chronic sinusitis. Acta Med Okayama 51: 33–7

    PubMed  Google Scholar 

  5. Kita H, Takezawa H, Isobe M, Kataura A (1995) Long-term low dose erythromycin (EM) and roxithromycin (RXM) therapy for chronic sinusitis. Pract Otol (Kyoto) (Suppl) 84: 62–9

    Google Scholar 

  6. Hashiba M, Baba S, Tohnai A, Okajima H, Matsuda T, Hondo J, Ohya H, Yokota A, Koto A, Ito M et al (1997) Clinical efficacy of long-term macrolides therapy for chronic sinusitis-comparison between erythromycin and clarithromycin. Pract Otol (Kyoto) 90: 717–27

    Google Scholar 

  7. Felstead SJ, Daniel R (1991) Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. J Int Med Res 19: 363–72

    PubMed  Google Scholar 

  8. Hashiba M, Suzaki H, Furuta S, Yanagi K, Ohyama M, Baba S (1998) Guideline for macrolide treatment of chronic paranasal sinusitis (draft). Jpn J Antibiot 51(Suppl A): 86–9

    PubMed  Google Scholar 

  9. Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A (1991) Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 58: 145–9

    PubMed  Google Scholar 

  10. Shinkawa A, Sakai M (1996) Study on the duration of long-term administration of roxithromycin (RXM) in patients with chronic sinusitis. ORL Tokyo 39(Suppl 1): 108–11

    Google Scholar 

  11. MacLeod CM, Hamid QA, Cameron L, Tremblay C, Brisco W (2001) Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Adv Ther 18: 75–82

    PubMed  Google Scholar 

  12. Suzuki H, Ikeda K, Honma R, Gotoh S, Oshima T, Furukawa M, Takasaka T (2000) Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 62: 121–7

    PubMed  Google Scholar 

  13. Hirano K, Ikeda K, Shimomura A, Ohshima T, Kondo Y, Takasaka T (1995) Clinical investigation of effectiveness and ineffectiveness in patients with chronic sinusitis in the treatment of newly developed macrolides. ORL Tokyo 38(Suppl 3): 251–7

    Google Scholar 

  14. Steinke JW, Borish L (2003) Clarification of terminology in patients with eosionopilic and noneosinophilic hyperplastic rhinosinusitis. Author reply. J Allergy Clin Immunol 112: 222–3

    Google Scholar 

  15. Moriyama H, Yanagi K, Ohtori N, Fukami M (1995) Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy. Rhinology 33:166–70

    PubMed  Google Scholar 

  16. Cervin A, Kalm O, Sandkull P, Lindberg S (2002) One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 126:481–9

    Article  PubMed  Google Scholar 

  17. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T (1997) Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med 182: 115–24

    PubMed  Google Scholar 

  18. Fujita K, Shimizu T, Majima Y, Sakakura Y (2000) Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells. Eur Arch Otorhinolaryngol 257: 199–204

    Article  PubMed  Google Scholar 

  19. Shimizu T, Shimizu S, Hattori R, Gabazza EC, Majima Y (2003) In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. Am J Respir Crit Care Med 168: 581–7

    Article  PubMed  Google Scholar 

  20. Kim DY, Takeuchi K, Ishinaga H, Kishioka C, Suzuki S, Basbaum C, Majima Y (2004) Roxithromycin suppresses mucin gene expression in epithelial cells. Pharmacology 72:6–11

    Article  PubMed  Google Scholar 

  21. Rhee CS, Majima Y, Arima S, Jung HW, Jinn TH, Min YG, Sakakura Y (2000) Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. Ann Otol Rhinol Laryngol 109: 484–7

    PubMed  Google Scholar 

  22. Kondoh K, Hashiba M, Baba S (1996) Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. Acta Otolaryngol (Suppl) 525: 56–60

    Google Scholar 

  23. Ozeki M, Miyamoto N, Hashiba M, Baba S (1996) Inhibitory effect of roxithromycin on biofilm formation of Pseudomonas aeruginosa. Acta Otolaryngol (Suppl) 525: 61–3

    Google Scholar 

  24. Ichimura K, Shimazaki Y, Ishibashi T, Higo R (1996) Effect of new macrolide roxithromyci upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 23: 48–56

    PubMed  Google Scholar 

  25. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H (2000) Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 14: 143–8

    PubMed  Google Scholar 

  26. Nonaka M, Pawankar R, Tomiyama S, Yagi T (1999) A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 13(4): 267–72

    PubMed  Google Scholar 

  27. Iino Y, Sugita K, Toriyama M, Kudo K (1993) Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 119: 648–51

    PubMed  Google Scholar 

  28. Iino Y, Sugita K, Ishitoya J, Nakai A, Ambe K, Masuda T, Shimizu H, Toriyama M (1992) Erythromycin treatment for otitis media with effusion in children. Pract Otol (Kyoto) 85: 713–20

    Google Scholar 

  29. Iino Y (2001) Efficacy of macrolide therapy for children with serous otitis media. Jpn J Antibiot 54(Suppl) C:23–5

    Google Scholar 

  30. Enomoto F, Ichikawa G, Nagaoka I, Yamashita T (1998) Effect of erythromycin on otitis media with effusion in experimental rat model. Acta Otolaryngol (Suppl)539: 57–60

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan

    Kazuhiko Takeuchi & Yuichi Majima

  2. McGill University, Canada

    Qutayba Hamid

Authors
  1. Kazuhiko Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuichi Majima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qutayba Hamid
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics School of Medicine, Wake Forest University, Medical Center Boulevard, Winston-Salem, NC, 27157-1081, USA

    Bruce K. Rubin

  2. First Department of Medicine, Tokyo Women’s Medical University, 8-1 Kawada-Cho, Shinjuku, Tokyo, 162-8666, Japan

    Jun Tamaoki

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Hirkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Takeuchi, K., Majima, Y., Hamid, Q. (2005). Macrolides and upper airway/sinus disease. In: Rubin, B.K., Tamaoki, J. (eds) Antibiotics as Anti-Inflammatory and Immunomodulatory Agents. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7310-5_12

Download citation

  • DOI: https://doi.org/10.1007/3-7643-7310-5_12

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-5925-6

  • Online ISBN: 978-3-7643-7310-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation